Our study investigated four biomarkers, providing promising results that are more comprehensive and detailed for diagnosing and staging chronic hepatitis B. Each biomarker captures a different aspect of the disease: GDF-15 (stress/injury), CCL-20 (inflammation), and CXCL-16/CD8a (T cell dynamics). The gene discussed is CD8A; the disease is chronic hepatitis B virus infection.